Table 1.
Demographic and biochemical characteristics of the patients
| Fibrosis stage | n | Male/female | Mean age (years) | Serum ALT (U/L) mean ± SEM | Serum AST (U/L) mean ± SEM | HCV (n) | HBV (n) | NASH (n) |
|---|---|---|---|---|---|---|---|---|
| F0 | 14 | 11/3 | 41.89 ± 4.16 | 69.2 ± 5.77 | 57.75 ± 12.52 | 4 | 2 | 10 |
| F1 | 9 | 8/1 | 46.8 ± 1.65 | 79.85 ± 15.3 | 70.43 ± 16.21 | 4 | 4 | 7 |
| F2 | 13 | 9/4 | 44 ± 1.31 | 84.25 ± 25.23 | 75.71 ± 13.07 | 8 | 4 | 5 |
| F3 | 34 | 24/10 | 45.47 ± 2.05 | 180.6 ± 25.8 | 136.67 ± 84.06 | 16 | 6 | 4 |
| F4 | 24 | 17/7 | 42.8 ± 1.54 | 191.63 ± 78.39 | 145.18 ± 59.23 | 14 | 4 | 2 |
| Total | 94 | 69/25 | 44.1 ± 1.1 | 114.62 ± 22.69 | 93.88 ± 16.46 | 46 | 20 | 28 |
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; HCV, hepatitis C virus; HBV, hepatitis B virus; NASH, nonalcoholic steatohepatitis; n, number; SEM, standard error of mean.